BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1316247)

  • 1. Immunodiagnostic aspects of autoantibodies against myeloperoxidase.
    Ulmer M; Rautmann A; Gross WL
    Clin Nephrol; 1992 Apr; 37(4):161-8. PubMed ID: 1316247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
    Gross WL; Csernok E; Flesch BK
    J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
    Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
    Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic antibodies: clinical characteristics of 10 patients with the perinuclear pattern of immunofluorescence on ANCA testing.
    Ecklund SR; Saluta GS; Agudelo CA; Pisko EJ
    South Med J; 1992 Feb; 85(2):132-8. PubMed ID: 1738878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to proteinase-3 and myeloperoxidase in systemic vasculitis].
    Baranov AA; Kirdianov SIu; Beketova TV; Bazhina OV; Gur'eva MS; Abaĭtova NE
    Ter Arkh; 2004; 76(5):22-8. PubMed ID: 15230127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
    Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.
    Falk RJ; Jennette JC
    N Engl J Med; 1988 Jun; 318(25):1651-7. PubMed ID: 2453802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
    Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A
    Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
    Savige JA; Gallicchio M; Georgiou T; Davies DJ
    Clin Exp Immunol; 1990 Nov; 82(2):238-43. PubMed ID: 1978702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
    Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
    Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
    J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rapidly progressive glomerulonephritis without immune deposits: detection of neutrophil anticytoplasmic antibodies].
    Castillo A; Valderrama G; Ardiles L; Caorsi I; Mezzano S
    Rev Med Chil; 1993 Mar; 121(3):260-4. PubMed ID: 8248637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of anti-neutrophil cytoplasmic antibodies by immunoprecipitation.
    Lucena-Fernandes F; Dalpé G; Dagenais P; Richard C; Calvert R; Boire G; Ménard HA
    Clin Invest Med; 1995 Jun; 18(3):153-62. PubMed ID: 7554581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-endothelial cell antibody as a marker of disease activity in Wegener's granulomatosis].
    Göbel U; Sima D; Briedigkeit L; Kettritz R; Sönnichsen N; Natusch R
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):541-4. PubMed ID: 7856259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.